Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15905493 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
Condition: Metastatic Breast Cancer
Interventions: Drug: placebo;   Drug: interleukin 7

Indicates status has not been verified in more than two years